e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Exploring alternative mechanisms and treatments
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vasorelaxant effect of hydrogen sulfide (H
2
S) in human isolated pulmonary vessels
S. Harrison, P. M. Gigli, A. Ianni, R. Patacchini, P. Geppetti (Florence, Parma, Italy)
Source:
Annual Congress 2005 - Exploring alternative mechanisms and treatments
Session:
Exploring alternative mechanisms and treatments
Session type:
Thematic Poster Session
Number:
3711
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Harrison, P. M. Gigli, A. Ianni, R. Patacchini, P. Geppetti (Florence, Parma, Italy). Vasorelaxant effect of hydrogen sulfide (H
2
S) in human isolated pulmonary vessels. Eur Respir J 2005; 26: Suppl. 49, 3711
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Changes in lung function in patients with human T cell lymphotropic virus (HTLV) associated myelopathy residents in the eastern Brazilian Amazon
Improvement science: Education in Europe
Palliative care or standard chemotherapy in lung cancer patients?
Related content which might interest you:
Changes of endogenous hydrogen sulfide in rat model of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 216s
Year: 2006
The anti-proliferative effect of endogenous and exogenous hydrogen sulfide upon human airway smooth muscle
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010
Effect of theophylline on endogenous hydrogen sulfide in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 671s
Year: 2006
N
-acetyl-L-cysteine reduces the increased vascular permeability and VEGF levels in lungs treated with hydrogen peroxide
Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel
in vitro
assays and results from animal models
Year: 2007
Pulmonary artery pressure (PAP) reduction by systemic and inhaled S-nitroso-N-acetyl-penicillamine (SNAP) in an isolated rabbit lung model of acute lung injury
Source: Eur Respir J 2002; 20: Suppl. 38, 37s
Year: 2002
Hydrogen gas alters the production of reactive oxygen species in alveolar epithelial cells
in vitro
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012
Increased generation of reactive oxygen species in pulmonary arterial smooth muscle cells, isolated from monocrotaline-treated rats
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009
Non-enzymatic hydrogen peroxide scavenging properties of normal human airway secretions
Source: Eur Respir J 2003; 22: Suppl. 45, 456s
Year: 2003
Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways
Source: Eur Respir J 2003; 22: 457-461
Year: 2003
Early atorvastatin administration suppresses the oxygen-activating ability of rat neutrophils during monocrotalinin-induced pulmonary arterial hypertension (PAH).
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
Hydrogen protects alveolar epithelial cells (A549) against injury induced by reactive oxygen species
in vitro
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010
Ample safety margins exist for clinical development of inhaled AIR001 (Sodium nitrite) in pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
Effects of PEEP-like cyclic stretch on the IL-6 protein production in normal human pulmonary artery endothelial cells
in vitro
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Effect of eNOS gene overexpression on the vascular reactivity of isolated pulmonary arteries of chronic hypoxic rats
Source: Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease"
Year: 2006
Acute neutrophilic airway inflammation is associated with a decrease in pulmonary ascorbic acid concentration but not an elevation of exhaled hydrogen peroxide
Source: Eur Respir J 2004; 24: Suppl. 48, 596s
Year: 2004
Hydrogen sulphide donors prevent hyperreactivity of mice tracheas in an in vitro lipopolysaccharide-induced inflammation model
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018
Histopathological studies on the effects of peroxynitrite on the lungs and trachea of rabbits
Source: Eur Respir J 2002; 20: 1014-1016
Year: 2002
Increased concentration of hydrogen peroxide (H
2
O
2
) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 247s
Year: 2001
Inhaled sodium nitrite attenuates hypoxic pulmonary vasoconstriction
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept